SGEN · Seagen
Acquired Company
Pfizer acquired Seagen for $229 per share in cash for a total enterprise value of approximately $43 billion, with the acquisition completed on December 14, 2023.
Seagen Inc., a biotechnology company, develops and markets cancer treatment therapies in the United States and internationally. The company is headquartered in Bothell, Washington.
Market Cap
43.15B
52 Wk Range
$0.00 - $0.00
Previous Close
$228.74
Open
$228.74
Volume
N/A
Day Range
$228.74 - $228.74
Enterprise Value
N/A
Cash
428.6M
Avg Qtr Burn
-35.82M
Insider Ownership
0.81%
Institutional Own.
88.83%
Qtr Updated
Sep 30th 2023